Navigation Links
Envera Increases Scientific Staff

West Chester, PA (PRWEB) February 14, 2013

Envera announced today the addition of Jeffrey Holt and Nantiya Abraham to the Research and Development staff. Dr. Holt enters the company as a Research Scientist with Mrs. Abraham serving as a Research Technician.

Mike Matheny, President and Owner of Envera stated, “The continued growth of our business, and Envera’s focus on research and development, has prompted the addition of laboratory personnel. We are pleased to have Dr. Holt and Mrs. Abraham join our team and I look forward to their assistance with several laboratory projects”, added Matheny. “With almost 20 years of combined laboratory experience I am sure they will have a positive impact on our future”, concluded Matheny.

Dr. Holt holds a Bachelor’s Degree in Microbiology from Ohio University, a Masters of Biotechnology from the University of Pennsylvania, and a Ph.D. in Biological Sciences from Drexel University. Jeff’s Ph.D thesis focused on the Isolation and Characterization of Novel Mutants of Campylobacter jejuni. Jeffrey brings Envera a diverse background in molecular biology, bacteriophage expertise, and an extensive background in animal pathogen infection and modeling.

Mrs. Abraham earned a Bachelor’s of Science Degree in Microbiology from Naresuan University. Nantiya spent 4 years as a Quality Control Analyst for Mead Johnson Nutrition Ltd, a manufacturer of infant formula and other milk products. While in this position Nantiya performed a variety of microbiological tests to insure the safety and quality of the Mead Johnson Nutrition product line in an ISO/IEC 17025 and GMP/GLP environment.

“I am excited to join Envera where I can apply my academic background to help solve real world issues”, stated Dr. Holt. “Envera’s focus on the development of environmentally friendly products is especially appealing to me”, finished Jeff. “I am looking forward to being part of a team focused on the use of beneficial microorganisms to replace harsh chemicals”, added Mrs. Abraham.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
2. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
3. Voltage increases up to 25 percent observed in closely packed nanowires at Sandia Labs
4. Transonic sponsors Flow Measurement workshop at 9th Annual Scientific meeting of the Society of Diagnostic and Interventional Nephrology
5. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
6. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
7. Prizmatix Introduces Ultra High Power LED with Over 4 Watts of Collimated White Light for Scientific and Industrial Applications
8. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
9. Source Scientific LLC is 100% Acquired by BIT Analytical Instruments
10. Announces New Tri-Fold Scientific Poster Service
11. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):